Patrick Finn
2019
In 2019, Patrick Finn earned a total compensation of $3M as Chief Commercial Officer at Twist Bioscience Corp.
Compensation breakdown
| Non-Equity Incentive Plan | $205,764 |
|---|---|
| Option Awards | $1,415,209 |
| Salary | $352,917 |
| Stock Awards | $1,039,793 |
| Total | $3,013,683 |
Finn received $1.4M in option awards, accounting for 47% of the total pay in 2019.
Finn also received $205.8K in non-equity incentive plan, $352.9K in salary and $1M in stock awards.
Rankings
In 2019, Patrick Finn's compensation ranked 4,075th out of 13,971 executives tracked by ExecPay. In other words, Finn earned more than 70.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,075 out of 13,971 | 71st |
Division Manufacturing | 1,473 out of 5,701 | 74th |
Major group Chemicals And Allied Products | 516 out of 2,200 | 77th |
Industry group Drugs | 435 out of 1,886 | 77th |
Industry Biological Products, Except Diagnostic Substances | 91 out of 389 | 77th |
Source: SEC filing on January 7, 2021.
Finn's colleagues
We found two more compensation records of executives who worked with Patrick Finn at Twist Bioscience Corp in 2019.